|

ASP3082 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Gustave Roussy, Cancer Campus, Grand Paris1

Indications

  • Metastatic/Locally Pancreatic Ductal Adenocarcinoma1
  • Metastatic/Locally Advanced Non-Small-Cell Lung Cancer1
  • Lung Cancer1
  • Cancer1

Other1 trial

Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.